Through ultrasensitive InSituPlex® assays and advanced, AI-driven spatial analysis, Ultivue empowers scientists developing precision cancer therapies to generate quantitative, high confidence insights in just a fraction of the time.


Our Purpose

 

We position researchers with the clearest profile – the best view – of cancer biology. Our technology enables scientists to see more, to see faster, and to see in situ.
Through achieving broad access to our ultrasensitive assays and spatial analysis tools in the study of tissue samples, we will equip customers with insights for high confidence, timely and cost-effective decisions. Together, we can revolutionize precision medicine.

Our Values

Ultivue employees are passionate, smart, collaborative, and work with a sense of accountability to achieve ambitious breakthroughs, in an innovative environment cultivating out-of-the-box thinking and appropriate risk-taking.

Ultivue is committed to supporting and strengthening our organization’s education, awareness, and long-term integration of Diversity, Equity, Inclusion & Belonging (DEIB).


Leadership

As a pioneer in the industry, Ultivue takes a leadership stance in spatial phenomics and provides meaningful and influential guidance

Innovation

Ultivue is a relentless innovator expanding the purview of the industry and redefining standards for spatial biology

Partnership

In technology and consulting, Ultivue is a curious, precise, rigorous, and helpful partner

Meet the executive team and board of directors

Meet the executive team and board of directors

Show more

Future of rapid growth

Ultivue is headquartered in Cambridge, Massachusetts with operations across North America and Europe

Ultivue is headquartered in Cambridge, Massachusetts with operations across North America and Europe
TOTAL INVESTOR CAPITAL RAISED TOTAL INVESTOR CAPITAL RAISED
EMPLOYEES AROUND THE WORLD EMPLOYEES AROUND THE WORLD
US, CANADA, EUROPE, CHINA, JAPAN US, CANADA, EUROPE, CHINA, JAPAN

Our promise

01 01

Its about the cancer-fighting warrior.

Anyone can be a cancer patient one day. That’s why we work to ensure that our products and services provide actionable answers that help drive the development of personalized cancer therapies.

 

 

 

02 02

We transcend the status quo.

It’s always been done that way; doesn’t mean it’s the only way. We actively work to uncover the biology of cancer with spatial phenomics to redefine the conventional.

 

 

 

03 03

We make informed decisions.

Decisions should be impactful – we use evidence-based data because your decisions matter.

 

 

 

04 04

We are partners.

We are part of a large global passionate team with many different skills – Everyone is important and together we help advance your oncology programs.

 

 

 

A history of innovation

A history of innovation

2023

  • A total of over $120M total investor capital raised since the inception of the company
  • Global operations across US, Europe and Asia
  • Launch of OmniVUE™
  • Launch of AI Ecosystem including spatial image analysis & data mining services

2021

  • $50M raised in Series D funding
  • Commercial & Manufacturing Scale-up
  • CLIA certification granted for Ultivue Services Lab
  • Launch of FlexVUE™
  • Digital Health initiative launched, and team established in Munich, Germany

2019

  • $37M raised in Series C fundings
  • First peer-reviewed customer publication
  • Launch of UltiMapper kits® (T-reg and MDSC – now FixVUE™ kits)
  • First Ultivue patent granted

2018

  • $14M raised in Series B funding
  • The first customer project was delivered and the 10-plex assay was developed in R&D
  • Launch of first UltiMapper kits® (PD-L1/PD1; APC and T-act – now FixVUE™ kits)
  • Establishment of Ultivue EMEA, Srl in Milan Italy
  • Doubled the size of our Cambridge, MA facility

2015

Ultivue was founded by David Walt and Peng Yin, both Professors at Harvard Medical School & Wyss Institute for Biologically Inspired Engineering.

$5M raised in Series A funding

Why work for Ultivue?

We believe that our Human Capital is our most valuable investment and continuously strive towards improvement in our engagement. We hire the best-in-class employees, and care deeply about our Ultivue Family. To us, working here shouldn’t feel like work, as we’re all joined by one thing that ultimately keeps us driven and unified: Revealing the true state of cancer.

We’re focused on many initiatives and tenets to nurture our culture here at Ultivue and help assure we put our people first.


 

Diversity, equity, inclusion and belonging.
We’ve chartered a DEI&B roadmap partnering with Enspira, experts in this arena. Everyone is welcome here.

We’ll give you the tools to continue learning.
We’ve launched Training and Development courses such as Essential Lab Training and weekly ‘Brunch and Learns’ with a different Subject Matter Experts.

Your input matters, and your voice will be heard.
Ultivue has a revamped Performance Enrichment Program (PEP) to align with a more employee driven performance management tool.

We’re determined to be the best.
Partnered with People Productive to shepherd us towards our Ultimate Culture and to be a Best Place to Work. Work hard, play hard. We offer great health benefits, 401(k) company match, unlimited PTO, and MUCH more!